Medicare Benefits Schedule - Item 73395

Re‑analysis of whole exome or genome data that is obtained in performing a service to which item 73392 applies, for characterisation of previously unreported germline gene variants related to the clinical phenotype, if:

(a) the re-analysis is requested by a consultant physician practising as a clinical geneticist or a cardiologist; and

(b) the patient is strongly suspected of having a heritable cardiomyopathy; and

(c) the re-analysis is performed at least 18 months after a service to which item 73392 or this item applies is performed for the patient

Applicable twice per lifetime

Fee: $500.00 Benefit: 75% = $375.00 85% = $425.00

(See para PN.0.23 of explanatory notes to this Category)

• Previous - Item 73394
• Next - Item 73396

Items 73297, 73300, 73305, 73334, 73339, 73340, 73393, 73394, 73417, 73418, 73440, 73441, 73442, 73443, and 73444

Prior to ordering these tests the ordering practitioner should ensure the patient (or approximate proxy) has given written informed consent. Testing should only be performed after genetic counselling. Appropriate genetic counselling should be provided to the patient either by the specialist treating practitioner, a genetic counselling service or a clinical geneticist on referral. Further counselling may be necessary upon receipt of the test results.

Items 73295, 73296, 73304, 73333, 73392, 73395, 73416 and 73419

Patients who are found to have any form of affected allele should be referred for post-test genetic counselling as there may be implications for other family members. Appropriate genetic counselling should be provided to the patient either by the specialist treating practitioner, a genetic counselling service or a clinical geneticist on referral.

Related Items: 73295 73296 73297 73300 73304 73305 73333 73334 73339 73340 73392 73393 73394 73395 73416 73417 73418 73419 73440 73441 73442 73443 73444